DBVT:NASDAQ
DBV Technologies SA - ADR
$12.51
arrow_upward
+6.11%(+0.72) 1D
$12.51
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 17, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBVT...
Open
$12.22
High
$12.62
Low
$12.22
Mkt. cap
807.08M
Avg. vol.
323.02K
Volume
158.77K
52-wk high
$26.18
52-wk low
$8.86
EPS
-$3.57
Beta
-0.95
Shares outstanding
62.88M
No. of employees
170
Open
$12.22
High
$12.62
Low
$12.22
Mkt. cap
807.08M
Avg. vol.
323.02K
Volume
158.77K
52-wk high
$26.18
52-wk low
$8.86
EPS
-$3.57
Beta
-0.95
Shares outstanding
62.88M
No. of employees
170
News stories
From web sources and news partners
Idéal Investisseur
·
11 hours ago
DBV Technologies stock rebounds by over 4%, 2nd in the SBF 120
Stock Traders Daily
·
19 hours ago
Responsive Playbooks and the DBVT Inflection
Idéal Investisseur
·
1 day ago
DBV Technologies shares rebound 2.5% but remain down 33.5% over 3 months
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA - ADR